Comparative gene expression profiles of intestinal transporters in mice, rats and humans
详细信息 查看全文
- 作者：Hye-Ryoung Kim ; Sung-Won Park ; Hee-Jung Cho ; Kyung-Ae Chae ; Ji-Min Sung ; Jin-Suk Kim ; Christopher P. L ; owski ; Duxin Sun ; A.M. Abd El-Aty ; Gordon L. Amidon ; Ho-Chul Shin
- 关键词：Gene expression ; Transporters ; Intestine ; Animals ; Humans
- 刊名：Pharmacological Research
- 出版年：2007
- 出版时间：September 2007
- 年：2007
- 卷：56
- 期：3
- 页码：224-236
- 全文大小：252 K
文摘
We have studied gene expression profiles of intestinal transporters in model animals and humans. Total RNA was isolated from duodenum and the mRNA expression was measured using Affymetrix GeneChip oligonucleotide arrays. Detected genes from the intestine of mice, rats, and humans were about 60 % of 22,690 sequences, 40 % of 8739, and 47 % of 12,559, respectively. A total of 86 genes involving transporters expressed in mice, 50 genes in rats, and 61 genes in humans were detected. Mice exhibited abundant mRNA expressions for peptide transporter HPT1, amino acid transporters CSNU3, CT1 and ASC1, nucleoside transporter CNT2, organic cation transporter SFXN1, organic anion transporter NBC3, glucose transporter SGLT1, and fatty acid transporters FABP1 and FABP2. Rats showed high expression profiles of peptide transporter PEPT1, amino acid transporters CSNU1 and 4F2HC, nucleoside transporter CNT2, organic cation transporter OCT5, organic anion transporter SDCT1, glucose transporter GLUT2 and GLUT5, and folate carrier FOLT. In humans, the highly expressed genes were peptide transporter HPT1, amino acid transporters LAT3, 4F2HC and PROT, nucleoside transporter CNT2, organic cation transporter OCTN2, organic anion transporters NADC1, NBC1 and SBC2, glucose transporters SGLT1 and GLUT5, multidrug resistance-associated protein RHO12, fatty acid transporters FABP1 and FABP2, and phosphate carrier PHC. Overall these data reveal diverse transcriptomic profiles for intestinal transporters among these species. Therefore, this transcriptional data may lead to more effective use of the laboratory animals as a model for oral drug development.